The record date is the date set by the company to decide the shareholders who are eligible to receive the offer. To be eligible for a buyba...

The reason for the popularity of PPIs among doctors and patients is not tough to gauge. With unhealthy lifestyles and dietary habits, acidi...

The Nifty Pharma index closed 0.27 per cent down at 15121.1.

The Nifty Pharma index was trading 0.03 per cent up at 15165.95.

The volumes were tepid in January, but with flu, Covid-19 and other viral infections spreading fast, February and March saw spikes in volum...

Government-appointed experts have been tasked with preparing the new NLEM to decide on which group of antibiotics should be included and ex...

New advice differentiating common antibiotics from those to be used for most serious medical conditions is likely in the revised National L...

The bioequivalence studies, necessary to gain approvals - were done by Indian CRO for large generic companies including Mylan Teva, Accord ...

The CBDT has set a target of Rs 2.56 trillion for Mumbai region, the largest tax region which contributes over a third of the total tax rev...

With many unlisted cos in sector, chances of them tapping mkt looks high: Nomura Fin's Oza.

Domestic drugmakers alleged that distributors and retailers are planning to boycott three leading companies — Sun Pharma, Cadila Healthcare...

A crackdown on female foeticide in Maharashtra has, triggering a shortage of medicines used to terminate unwanted pregnancies.

Growth in the domestic pharma market dipped in September over the previous month, but was still nearly double digit at 9.6%.

Piramal Healthcare’s cough syrup Phensedyl has toppled Swiss drug major Novartis’s pain killer brand Voveran to emerge as the country’s lar...

Govt is contemplating issuing safety alerts on these medicines highlighting the risk of heart failure.

The pharma sector has set off this fiscal on a high note with the industry having posted a 21.8% cumulative growth in April.